KALA BIO, Inc. (FRA:27F0)
Germany
· Delayed Price · Currency is EUR 0.924
+0.109 (13.31%)
At close: Dec 4, 2025
KALA BIO Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Revenue | - | - | - | 3.89 | 11.24 | 6.36 | Upgrade
|
| Revenue Growth (YoY) | - | - | - | -65.37% | 76.67% | 4.74% | Upgrade
|
| Cost of Revenue | - | - | - | 2.56 | 4.1 | 2.67 | Upgrade
|
| Gross Profit | - | - | - | 1.33 | 7.14 | 3.69 | Upgrade
|
| Selling, General & Admin | 17.97 | 18.34 | 20.57 | 65.04 | 105.06 | 81.07 | Upgrade
|
| Research & Development | 23.67 | 22.09 | 18.59 | 17.65 | 11.52 | 18.35 | Upgrade
|
| Operating Expenses | 41.64 | 40.43 | 39.15 | 82.69 | 116.58 | 99.42 | Upgrade
|
| Operating Income | -41.64 | -40.43 | -39.15 | -81.36 | -109.43 | -95.73 | Upgrade
|
| Interest Expense | -4.53 | -5.78 | -5.81 | -7.27 | -8.38 | -8.59 | Upgrade
|
| Interest & Investment Income | 1.62 | 2.06 | 2.71 | 0.66 | 0.1 | 0.49 | Upgrade
|
| Other Non Operating Income (Expenses) | 5.46 | 6.2 | 3.97 | -0.93 | - | - | Upgrade
|
| EBT Excluding Unusual Items | -39.09 | -37.96 | -38.29 | -88.88 | -117.71 | -103.83 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | 4.2 | 47 | - | - | Upgrade
|
| Asset Writedown | -1.41 | - | -7.6 | - | - | -0.5 | Upgrade
|
| Other Unusual Items | 4.66 | -0.55 | -0.51 | -2.93 | 1.72 | - | Upgrade
|
| Pretax Income | -35.84 | -38.51 | -42.2 | -44.82 | -142.61 | -104.33 | Upgrade
|
| Net Income | -35.84 | -38.51 | -42.2 | -44.82 | -142.61 | -104.33 | Upgrade
|
| Net Income to Common | -35.84 | -38.51 | -42.2 | -44.82 | -142.61 | -104.33 | Upgrade
|
| Shares Outstanding (Basic) | 6 | 4 | 2 | 2 | 1 | 1 | Upgrade
|
| Shares Outstanding (Diluted) | 6 | 4 | 2 | 2 | 1 | 1 | Upgrade
|
| Shares Change (YoY) | 86.46% | 56.09% | 59.94% | 15.50% | 25.67% | 53.11% | Upgrade
|
| EPS (Basic) | -5.83 | -10.15 | -17.35 | -29.48 | -108.32 | -99.59 | Upgrade
|
| EPS (Diluted) | -5.83 | -10.15 | -17.35 | -29.48 | -108.32 | -99.59 | Upgrade
|
| Free Cash Flow | -32.12 | -29.59 | -28.54 | -79.22 | -109.12 | -92.64 | Upgrade
|
| Free Cash Flow Per Share | -5.22 | -7.79 | -11.73 | -52.10 | -82.89 | -88.43 | Upgrade
|
| Gross Margin | - | - | - | 34.22% | 63.55% | 57.98% | Upgrade
|
| Operating Margin | - | - | - | -2090.34% | -973.60% | -1504.73% | Upgrade
|
| Profit Margin | - | - | - | -1151.64% | -1268.73% | -1639.85% | Upgrade
|
| Free Cash Flow Margin | - | - | - | -2035.48% | -970.83% | -1456.08% | Upgrade
|
| EBITDA | -41.31 | -40.18 | -38.85 | -80.82 | -108.46 | -94.82 | Upgrade
|
| D&A For EBITDA | 0.33 | 0.26 | 0.3 | 0.54 | 0.98 | 0.91 | Upgrade
|
| EBIT | -41.64 | -40.43 | -39.15 | -81.36 | -109.43 | -95.73 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.